← Back
$ARQT All transactions

Arcutis Biotherapeutics, Inc.

▼ SELL

$ Value

$52K

Shares

2,052

Price

$25

Filed

Feb 4

Insider

Name

Edwards Larry Todd

Title

See Remarks

CIK

0001994805

Roles

Officer

Transaction Details

Transaction Date

2026-02-02

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

148,865

Footnotes

The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligation in connection with the vesting of Restricted Stock Units ("RSUs"), granted on January 12, 2024, in which 25% of the RSUs vest annually on February 1, (the "Vesting Commencement Date"), of each year beginning on February 1, 2025, subject to the Reporting Person's continued service to the Issuer. | The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $24.745 to $25.68, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. | Includes 724 shares purchased under the Issuer's Employee Stock Purchase Plan on November 30, 2025.

Filing Info

Accession No.

0001628280-26-005566

Form Type

4

Issuer CIK

0001787306

Edwards Larry Todd's History

Date Ticker Type Value
2026-03-02 ARQT $90K
2026-03-02 ARQT $3K
2026-02-27 ARQT A $0
2026-02-27 ARQT A $0
2026-02-02 ARQT $52K
2025-11-06 ARQT $733K
2025-10-02 ARQT $84K
2025-10-02 ARQT $6K
2025-05-19 ARQT $105K

Other Insiders at ARQT (90d)

Insider Bought Sold Last
Leonard Keith R $997K 2026-03-02
Burnett Patrick
See Remarks
$505K 2026-03-02
Matsuda Masaru
See Remarks
$1.3M 2026-03-02
Welgus Howard G. $746K 2026-04-01
Watanabe Todd
See Remarks
$1.4M 2026-03-02
Edwards Larry Todd
See Remarks
$93K 2026-03-02
Vairavan Latha
SVP Chief Financial Officer
$106K 2026-03-02